Commit To Buy BioCryst Pharmaceuticals At $3, Earn 40.4% Annualized Using Options
July 27, 2016 at 11:48 AM EDT
Investors considering a purchase of BioCryst Pharmaceuticals, Inc. (BCRX) shares, but cautious about paying the going market price of $3.28/share, might benefit from considering selling puts among the alternative strategies at their disposal..